Jeffrey Matous
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment
Papers in
- Hematology 63
- Multiple Myeloma Research and Treatments 55
- Chronic Myeloid Leukemia Treatments 9
- Genetics 59
- Chronic Lymphocytic Leukemia Research 58
- Co-authors
- Ranjana H. Advani (20 shared papers)Radhakrishnan Ramchandren (11 shared papers)Michelle A. Fanale (13 shared papers)Nancy L. Bartlett (13 shared papers)Joseph D. Rosenblatt (10 shared papers)Pauline Brice (8 shared papers)Steven P. Treon (33 shared papers)Andrei R. Shustov (10 shared papers)
- Journals
- Blood (68 papers)Journal of Clinical Oncology (20 papers)Seminars in Hematology (5 papers)Clinical Cancer Research (4 papers)HemaSphere (4 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Jeffrey Matous
120 papers receiving 4.2k citations
Jeffrey Matous's Hit Papers
Peers
Comparison fields: 5 of 78
- Genetics 1.5k
- Pathology and Forensic Medicine 2.0k
- Hematology 1.1k
- Oncology 1.6k
- Dermatology 351
Countries citing papers authored by Jeffrey Matous
This map shows the geographic impact of Jeffrey Matous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Matous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Matous more than expected).
Fields of papers citing papers by Jeffrey Matous
This network shows the impact of papers produced by Jeffrey Matous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Matous. The network helps show where Jeffrey Matous may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey Matous, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study Hit paper breakdown → | 2012 | 719 |
| 2 | 2018 | 239 | |
| 3 | 2009 | 192 | |
| 4 | Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results Hit paper breakdown → | 2023 | 177 |
| 5 | 2019 | 175 | |
| 6 | 2017 | 166 | |
| 7 | 2018 | 155 | |
| 8 | 2014 | 137 | |
| 9 | 2010 | 129 | |
| 10 | 2007 | 126 | |
| 11 | 2010 | 117 | |
| 12 | 2012 | 108 | |
| 13 | 2008 | 103 | |
| 14 | 2007 | 102 | |
| 15 | 2010 | 101 | |
| 16 | 2011 | 81 | |
| 17 | 2013 | 77 | |
| 18 | 2021 | 70 | |
| 19 | 2010 | 70 | |
| 20 | 2009 | 62 |
About Jeffrey Matous
Jeffrey Matous is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Molecular Biology, having authored 128 papers that have together received 4.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (58 papers), Multiple Myeloma Research and Treatments (55 papers), Lymphoma Diagnosis and Treatment (44 papers), Protein Degradation and Inhibitors (23 papers), Cancer Treatment and Pharmacology (13 papers), CAR-T cell therapy research (11 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Immunodeficiency and Autoimmune Disorders (9 papers). The work is most often cited by research in Genetics (1.5k citations), Pathology and Forensic Medicine (2.0k citations), Hematology (1.1k citations), Oncology (1.6k citations) and Dermatology (351 citations). Jeffrey Matous has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Ranjana H. Advani, Radhakrishnan Ramchandren, Michelle A. Fanale, Nancy L. Bartlett, Joseph D. Rosenblatt, Pauline Brice, Steven P. Treon, Andrei R. Shustov, Dana A. Kennedy and Tim Illidge. Their work appears in journals such as Blood, Journal of Clinical Oncology, Seminars in Hematology, Clinical Cancer Research and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.